HOME
HIV and AIDS
Hepatitis C
Hepatitis B
HIV-HCV Coinfection
HIV-HBV Coinfection
HIV and AIDS Main Section
FDA-approved Treatments
Experimental Treatments
Library of CME Programs

 Google Custom Search
Adverse Events
Anemia | Liver Toxicity
Depression | Kidney Toxicity ...
Opportunistic Infections
Tuberculosis | Candidiasis | Pneumonia
CMV Retinitis
| HPV | PCP ...
Metabolic Complications
Cardiovascular Disease | Cholesterol
Diabetes | Insulin Resistance ...
Lipodystrophy - Fat Redistribution
Fat Loss | Fat Accumulation
Wasting | Cosmetic Procedures ...
HIV and AIDS Top News Articles
Reduced Immune Activation Predicts Better Response to Salvage Therapy for Highly Treatment-experienced HIV Patients - 6/24/08
Viral Genetic Variations Predict Response to HIV Maturation Inhibitor Bevirimat - 6/24/08
Kaposi Sarcoma (KS) in HIV Negative Men Who Have Sex with Men - 6/24/08
Abdominal Fat Accumulation, Elevated ALT, and Liver Steatosis in HIV Positive Individuals - 6/24/08
CDC Addresses False Positive Results of Oral Fluid Rapid HIV Antibody Tests - 6/24/08
Initiating Anti-HIV Therapy: When to Start and What to Use - 6/20/08
Studies Find Minimal Cardiovascular Benefit and Increased Mortality with Intensive Glucose Management for People with Type 2 Diabetes - 6/20/08
Adding Tenofovir (Viread) plus Emtricitabine (Emtriva) to Short-course Zidovudine (Retrovir) and Single-dose Nevirapine (Viramune) Does Not Reduce the Risk of Mother-to-child HIV Transmission - 6/20/08
Phase 3 Study Shows Growth Hormone Releasing Factor Tesamorelin Reduces Excess Visceral Fat in HIV patients - 6/20/08
Idenix Reports Promising Results from Clinical Trial of Experimental NNRTI IDX899 - 6/20/08
Extended Antiretroviral Prophylaxis Lowers Risk of Mother-to-child HIV Transmission during Breast-feeding, but Early Weaning Is Detrimental - 6/17/08
High-concentration Capsaicin Patch Is Beneficial for Treatment of Painful HIV-related Neuropathy - 6/17/08
Low Tidal Volume Ventilation Is Associated with Reduced Mortality in HIV Patients with Acute Lung Injury - 6/17/08
More than 40% of Gay Men with HIV in the U.K. Are Undiagnosed, and 60% of Them Believe They Are HIV Negative - 6/17/08
FDA and European Medicines Agency Will Consider New Biomarker Test Results When Assessing Kidney Toxicity of Experimental Drugs - 6/17/08
HAART Regimen Changes Due to Drug Toxicities in HIV Positive People with Virological Suppression - 6/13/08
Durability and Outcomes of First-line Antiretroviral Regimens - 6/13/08
Long-term Efficacy and Tolerability of Regimens Containing Efavirenz (Sustiva) and Nevirapine (Viramune) Regimens - 6/13/08
HIV Patients Taking Efavirenz (Sustiva) Experience Fewer Oral Lesions than Those on Protease Inhibitors - 6/13/08
Roche Updates Package Insert for HIV Protease Inhibitor Saquinavir (Invirase) - 6/13/08
Is Efavirenz (Sustiva) the Best Option for First-line HIV Therapy? - 6/10/08
Double-boosted Protease Inhibitors Saquinavir (Invirase) and Lopinavir/ritonavir (Kaletra) Produce Significant CD4 Rise and Viral Load Decline in Treatment-experienced Children - 6/10/08
New More Sensitive "Trofile" HIV CCR5/CXCR4 Tropism Test Now Available - 6/10/08
NIAID to Fund Novel B-Cell Approach to HIV Vaccine Development - 6/10/08
Gilead and Boehringer Freeze Prices on Viread and Truvada to U.S. Agencies - 6/06/08
World Health Organization, UNAIDS, and UNICEF Release New Report on Global HIV/AIDS Treatment - 6/06/08
Resistance Testing Leads to Effective Treatment for Virological Rebound in Patients on Salvage HAART Regimens - 6/06/08
Anti-PGL-TB-1 Antibodies Predict Lack of Immune Restoration Syndrome in HIV Positive Patients with Tuberculosis - 6/06/08
New Automated HIV Antibody Test Produces Results in Less than 50 Minutes - 6/06/08
High-density Lipoprotein (HDL) Cholesterol in People with HIV: Association with Viral Load and Antiretroviral Therapy - 6/03/08
Ezetimibe Combined with Low-dose Statin Drugs Effectively Reduces Low Density Lipoprotein (LDL) in HIV Patients on Protease Inhibitors - 6/03/08
Bacterial Vaginosis, Not HIV, Is Primarily Responsible for Increased Concentrations of Vaginal Proinflammatory Cytokines - 6/03/08
Oral Therapy Reduces Incidence of Bacterial Vaginosis and Promotes Vaginal Health in HIV Positive Women - 6/03/08
Long-term Alcohol Abuse Is Linked to Worse Liver Fibrosis in HIV Positive Veterans with or without HCV Coinfection - 6/03/08
International Pharmaceuticals Issues Recall of "Viril-ity-Power" (VIP) Tabs, Sold as a Dietary Supplement for Sexual Enhancement - 6/03/08
Large Study Finds Several Types of Non-AIDS-defining Cancer Are More Common in HIV Positive People - 5/30/08
NIAID Halts ACTG 5175 Clinical Trial Arm Receiving Once-daily Atazanavir (Reyataz), Emtricitabine (Emtriva), and Didanosine (Videx) - 5/30/08
Trizivir plus Tenofovir (Viread) Prevents Immunological Decline in Patients with Multidrug-resistant HIV - 5/30/08
Long-term Fat Loss among Treatment-naive Patients Starting Combination Therapy Containing Stavudine (Zerit), Zidovudine (Retrovir), or Abacavir (Ziagen) - 5/30/08
FDA Warns Against Use of Xiadafil for Sexual Enhancement or Erectile Dysfunction - 5/30/08
FDA Proposes New Rule to Provide Updated Information on Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding - 5/30/08
FDA and Pfizer Set Specifications Allowing Nelfinavir (Viracept) to Again Be Prescribed for Children and Pregnant Women - 5/23/08
Gastrointestinal Symptoms Are Uncommon during Early HIV Infection, Despite CD4 Cell Depletion in the Gut - 5/23/08
Tibotec Launches New Higher Dosage Strength of Darunavir (Prezista) Tablet - 5/23/08
Inflammatory Bowel Disease in HIV Positive Individuals - 5/23/08
Controlling Cholesterol with Statins - 5/23/08
Benefits of Adding Viral Load or CD4 Cell Count Monitoring to Clinical Monitoring Alone Are Modest - 5/16/08
Does Tenofovir (Viread) Increase Liver Toxicity Related to Efavirenz (Sustiva)? - 5/16/08
Body Fat and Blood Lipid Levels in Men and Women with HIV - 5/16/08
Body Shape Changes in HIV Positive and HIV Negative Women - 5/16/08
Worsening Cardiovascular Risk among HIV Positive Individuals in D:A:D Study Has Not Led to an Increase in Heart Attacks - 5/13/08
Interaction between Lopinavir-ritonavir (Kaletra) and Rosuvastatin (Crestor) Reduces Drug's Lipid-lowering Effect - 5/13/08
Antiretroviral Therapy and Other Interventions Can Nearly Eliminate Risk of Mother-to-Child HIV Transmission - 5/13/08
Persistent AIDS-related Kaposi Sarcoma in the HAART Era Reveals Need for New Therapies - 5/09/08
Rapid Scale-up of Antiretroviral Therapy in South Africa Could Reduce HIV/AIDS Deaths by 1.3 Million bYear 2012 - 5/09/08
Higher CD4 Count Predicts Lower Risk of AIDS-related and Non-AIDS Illness, even above 350 Cells/mm3 - 5/06/08
Patients with CXCR4-tropic or Mixed-tropic HIV Experience Faster CD4 Cell Decline and May Benefit from Earlier Treatment - 5/06/08
NIAID Research Priorities to Fight Drug-resistant Tuberculosis - 5/06/08
Treatment Options for Osteopenia and Osteoporosis in HIV Patients - 5/02/08
HLA B*5701 Genetic Test Predicts Abacavir Hypersensitivity in Black as well as White HIV Patients - 5/02/08
Genetic Variation Predicts Higher Risk of Lipoatrophy in Patients on HAART - 5/02/08
Interrupting Antiretroviral Therapy Does Not Reduce the Risk of Cardiovascular Disease: Final Results of ACTG 5102 - 4/29/08
Tolerability and Effectiveness of First-line Treatment with Nevirapine and Lamivudine plus Zidovudine or Stavudine - 4/29/08
Efficacy and Safety of Once-daily Regimens in the Treatment of HIV Infection - 4/24/08
Following Antiretroviral Treatment Guidelines Produces the Best Results in Women with HIV - 4/24/08
Interactions between the Anti-fungal Agent Voriconazole (Vfend) and Antiretroviral Drugs- 4/24/08
CD4 Cell Recovery after Initiation of HAART in Treatment-naive Patients - 4/18/08
Fish Oil with or without Fenofibrate Reduces Elevated Triglycerides in HIV Patients on HAART - 4/18/08
Resistance Profile of the New Protease Inhibitor Darunavir (Prezista)  - 4/15/08
Elevated Fibrinogen Levels Linked to Protease Inhibitors May Contribute to Elevated Cardiovascular Risk  - 4/15/08
New Report Says 2.1 Million Children Worldwide Are Living with HIV/AIDS  - 4/15/08
Management of HIV Positive Men with Prostate Cancer in the HAART Era  - 4/11/08
Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People  - 4/11/08
Lower-Strength Lopinavir/Ritonavir (Kaletra, Aluvia) Tablet Approved in Europe for Children with HIV  - 4/11/08
"Women Living Positive: It's My Life" National Summit Webcast  - 4/11/08
Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children - 4/04/08
Is There a Potential Role for Ritonavir-boosted Protease Inhibitor Monotherapy? - 4/01/08
 

Reports on Most Recent HIV-related Research Conferences

CROI 2008 - February 2008 
IAS 2007 - July 2007 

Protease Inhibitors
Agenerase (amprenavir)
Aptivus (tipranavir)
Crixivan (indinavir)
Invirase (saquinavir hard gel)
Kaletra (lopinavir/ritonavir)
Lexiva (fosamprenavir)
Norvir (ritonavir)
Prezista (darunavir)
Reyataz (atazanavir)
Viracept (nelfinavir)
Nucleoside / Nucleotide Reverse Transcriptase Inhibitors
Combivir (zidovudine/lamivudine)
Epivir (lamivudine; 3TC)
Emtriva (emtricitabine; FTC)
Epzicom (abacavir + lamivudine)
Retrovir (zidovudine; AZT)
Trizivir (abacavir + zidovudine +lamivudine)
Truvada  (tenofovir / emtricitabine)
Videx (didanosine; ddI)
Viread (tenofovir)
Zerit (stavudine; d4T)
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Etravirine (Intelence; TMC125)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon (enfuvirtide, T-20)
Selzentry ( maraviroc)
Fixed-dose Combinations
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir (zidovudine + lamivudine)
Trizivir (abacavir + zidovudine + lamivudine)
Truvada (tenofovir + emtricitabine)
Integrase Inhibitor
Isentress (raltegravir)